- Filed
- Apr 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 7, 2025 | 27.18M sh |
| Cash And Equivalents | Q2 2025 · Feb 28, 2025 | $199.46K |
| Cash And Equivalents | Q2 2025 · Aug 31, 2024 | $152.99K |
| Current Liabilities | Q2 2025 · Feb 28, 2025 | $2.38M |
| Current Liabilities | Q2 2025 · Aug 31, 2024 | $1.68M |
| Total Liabilities | Q2 2025 · Feb 28, 2025 | $2.44M |
| Total Liabilities | Q2 2025 · Aug 31, 2024 | $1.8M |
| Current Assets | Q2 2025 · Feb 28, 2025 | $726.1K |
| Current Assets | Q2 2025 · Aug 31, 2024 | $790.75K |
| Total Assets | Q2 2025 · Feb 28, 2025 | $54M |
| Total Assets | Q2 2025 · Aug 31, 2024 | $53.28M |
| Revenue | Q2 2025 · Feb 28, 2025 | $9.45K |
| Shares Diluted restated | Q2 2025 · Feb 29, 2024 | 25.69M sh |
| Shares Diluted restated | Q2 2025 · Feb 29, 2024 | 25.67M sh |
| Capex | Q2 2025 · Feb 29, 2024 | $96.19K |
| Operating Cash Flow | Q2 2025 · Feb 29, 2024 | −$457.61K |
| Eps Diluted restated | Q2 2025 · Feb 29, 2024 | −$0.05 |
| Eps Diluted restated | Q2 2025 · Feb 29, 2024 | −$0.11 |
| Eps Basic restated | Q2 2025 · Feb 29, 2024 | −$0.05 |
| Eps Basic restated | Q2 2025 · Feb 29, 2024 | −$0.11 |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $1.47M |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $2.95M |
| Net Income | Q2 2025 · Feb 29, 2024 | −$1.37M |
| Net Income | Q2 2025 · Feb 29, 2024 | −$2.81M |
| Operating Income | Q2 2025 · Feb 29, 2024 | −$1.52M |
| Operating Income | Q2 2025 · Feb 29, 2024 | −$3.05M |
| Gross Profit | Q2 2025 · Feb 29, 2024 | −$45.9K |
| Gross Profit | Q2 2025 · Feb 29, 2024 | −$54.91K |
| Cost Of Revenue | Q2 2025 · Feb 29, 2024 | $87.08K |
| Cost Of Revenue | Q2 2025 · Feb 29, 2024 | $187.4K |